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It has been estimated that 20% of patients who undergo 
coronary angiography for the evaluation of chest pain have 
angiographically normal coronary vessels with no other car•
diac cause for their discomfort. Although the natural history 
of this patient group is favorable (1-3), the mechanisms 
responsible for the pain frequently remain mysterious. In 
the 1960s the explanations commonly given for this syn•
drome were a noncardiac cause of the pain (for example, 
esophageal spasm) and an inadequate number of angio•
graphic projections to exclude coronary obstructive lesions 
or coronary spasm. In addition, a psychogenic cause was 
suspected in many such patients. It is now generally agreed 
that these mechanisms are not responsible for causing chest 
pain in the majority of patients with angina and normal 
coronary vessels. 
Measuring the coronary reserve. In the past 5 to 10 
years it has become increasingly evident that there are many 
disease states associated with decreased coronary reserve 
and angiographically normal coronary vessels. Ideally, 
coronary reserve should be assessed by measuring the min•
imal coronary vascular resistance in each of the transmural 
layers of the left ventricular myocardium served by major 
coronary vessels (4). Because this cannot be accomplished 
in humans with available methods, a composite index of 
coronary reserve is usually obtained by measuring the dif•
ference between resting and maximal coronary flow over 
all layers. In normal humans, the ratio between resting and 
maximal coronary flow is between 4 and 6 (5). 
Role of cardiac hypertrophy. Almost all causes of 
pathologic cardiac hypertrophy are associated with substan-
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tial decreases in coronary reserve (6). Furthermore, the dec•
rement in coronary reserve is often of sufficient severity to 
produce ischemia in the face of only a moderate increase 
in cardiac metabolism. The best known syndrome in this 
group of disease entities is angina pectoris in patients with 
severe stenosis, normal vessels and marked left ventricular 
hypertrophy (7). 
Because systemic hypertension is by far the most com•
mon cause of cardiac hypertrophy in the western world and 
this type of cardiac enlargement is also associated with 
decreased coronary reserve (8-10), an accurate assessment 
of left ventricular mass should be performed in patients with 
"unexplained" angina pectoris. Although it might be sus•
pected that the decrement in coronary reserve would be 
proportional to the severity of the cardiac hypertrophy, this 
has not been convincingly demonstrated in clinical or animal 
studies (7-10). It is of interest that systemic hypertension 
was present in about two thirds of the patients reported by 
Legrand et al. (II) in this issue of the Journal. It is likely 
that some of these patients had left ventricular hypertrophy 
that may have been responsible for their decreased coronary 
reserve. 
Other potential causes of decreased coronary re•
serve. In addition to cardiac hypertrophy, other potential 
mechanisms of impaired coronary reserve in the presence 
of angiographically normal coronary vessels include severe 
anemia (12,13), polycythemia (13,14), hypoxia (13), ab•
normalities that adversely affect oxyhemoglobin dissocia•
tion (13), "syndrome x" (15,16) and previous myocardial 
infarction. Also, many patients with angiographically un•
detected diffuse coronary atherosclerosis and superimposed 
"minor luminal irregularities" are mistakenly told that they 
have no significant anatomic involvement of the coronary 
vessels. Such abnormalities can only be defined precisely 
by quantitative coronary angiography which can provide 
absolute measurements of the luminal cross-sectional area 
(17,18). Unfortunately, this procedure was not performed 
in the study reported by Legrand et al. (11). Although their 
studies have some imperfections, the results do contribute 
meaningful. new knowledge in this area and have two im•
portant implications. 
Implications of studies of Legrand et al. First, when•
ever possible, cardiologists should actively determine po•
tential mechanisms that may explain the pathogenesis of 
myocardial ischemia in patients with apparently normal 
coronary vessels and the syndrome of angina pectoris. In 
addition to excluding coronary spasm by ergonovine testing 
in appropriate patients, quantitative measurements of lu•
minal diameter of the major coronary branches should be 
obtained to exclude diffuse coronary disease (17). Left ven•
tricular mass should be measured precisely, metabolic evi•
dence of ischemia should be sought and coronary reserve 
should be measured directly. Obviously, available methods 
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will be needed at the community level to make such mea•
surements possible on a routine basis, Efforts to accomplish 
this are ongoing. In the near future, automated quantitative 
coronary angiography and videodensitometry will be more 
readily available in association with digital subtraction an•
giographic systems. Also, accurate methods of assessing 
left ventricular mass will be feasible with sophisticated to•
mographic imaging techniques including single photon 
emission tomography (19), magnetic resonance imaging (20) 
and cine computed tomography (21). Myocardial metabo•
lism can be crudely assessed by measuring substances such 
as lactate in coronary venous blood or more elegant studies 
of myocardial metabolism can be obtained with positron 
emission tomography or magnetic resonance imaging. The 
most promising methods of measuring coronary flow include 
positron emission tomography (22), cine computed tomog•
raphy (23), argon clearance (8,15), an intracoronary Dop•
pler catheter (24), xenon clearance (25) and improved digital 
subtraction angiography. Cine computed tomography is the 
only current approach that may permit measurements of 
perfusion in both the subendocardial and subepicardial lay•
ers of the left ventricle. With these approaches to measuring 
coronary flow it will be possible to obtain flow measure•
ments under control conditions and during maximal coro•
nary dilation achieved with either intravenous dipyridamole 
(24) or intracoronary papaverine (26). Intracoronary con•
trast, the vasodilator agent used in this study reported by 
Legrand et al. (II), is not an ideal coronary dilator because 
it produces submaximal and somewhat variable coronary 
dilation (24). Studies that employ this type of dilator provide 
at best only an index of coronary reserve. 
A second important implication of the study reported by 
Legrand et al. (11) is that the widespread practice of using 
patients with "angiographically normal coronary vessels" 
to determine the specificity of noninvasive imaging tech•
niques for diagnosing myocardial ischemia (thallium-20l 
scintigraphy and exercise radionuclide angiography, for ex•
ample) should be seriously questioned. An unknown per•
centage of such patients have impaired coronary reserve. 
To minimize this problem in the future it will be necessary 
to restrict the normal group for such studies to normal young 
volunteers without coronary risk factors and presumed nor•
mal coronary anatomy or patients with angiographically nor•
mal coronary vessels who have been demonstrated to have 
normal coronary vasodilator reserve. 
Conclusions. For almost two decades, the visual inter•
pretation of the coronary angiogram has been the standard 
utilized to determine physiologically significant coronary 
obstructions and to identify a subgroup of patients with 
angina and normal coronary arteries. We hope that it will 
not be many more years before the fallacy of this approach 
is widely recognized and that diagnostic evaluation of pa•
tients suspected of myocardial ischemia will include quan•
titative coronary angiography, a direct assessment of coro•
nary reserve and myocardial metabolism in the major coronary 
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vascular territories. When this becomes standard practice, 
the number of patients with unexplained "angina pectoris" 
is likely to be a small fraction of what it is today. 
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